In this CMMRD syndrome, homozygous carriers of PMS2 gene mutation develop brain cancers in the first decade of life and 40% of patients may develop a second primary tumor (Ramchander et al., 2017). This evidence concerns the gene PMS2 and Constitutional mismatch repair deficiency syndrome.